Results - Announcements
Bliss GVS Pharma Ltd share price ticked higher by 1.01% to Rs 650.05 after the company's net profit grew slightly 3.83% to Rs 53.34 crore, while revenue from operations improved marginally 9.73% to Rs 313.37 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.28%. It has marginally improved by 3.87% over last one week and crept higher by 0.06% in last one month while the market capitalization of Bliss GVS Pharma Ltd has improved by 1.53% and 39.26% in the same period respectively.
Profit before tax (PBT) of Bliss GVS Pharma Ltd stood at Rs 75.1 crore in Q3 FY26, rallying 84.84% year-on-year, and slipping 0.50% quarter-on-quarter. EBITDA came in at Rs 72 crore, jumping 106.42% YoY and easing 8.22% sequentially.
Total expenses increased by 11.03% to Rs 243.28 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 135.82 crore, surging by 43.51% YoY, while employee benefits expense was at Rs 44.99 crore, ticking higher by 4.51% YoY.
For the TTM ended FY26, revenue from operations rose 14.50% to Rs 927.11 crore, while net profit soared by 49.27% to Rs 134.73 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 9326% to Rs 90.5 crore, and PBT jumped 50.90% to Rs 189.59 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 138.72 crore in FY26, as against Rs 105.91 crore in FY25.
Bliss GVS Pharma Ltd surged by 327.52% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.45% during the same period.